Beathard Robert King 3rd 13D and 13G filings for Sunshine Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-07-29 4:45 pm Purchase |
2021-07-20 | 13G | Sunshine Biopharma, Inc. SBFM |
Beathard Robert King 3rd | 98 8.070% |
98 (New Position) |
Filing |